Market

STEQEYMA ® (ustekinumab-stba), a biosimilar to STELARA ® (ustekinumab), now available in the United States

STEQEYMA ® (ustekinumab-stba), a biosimilar to STELARA ® (ustekinumab), now available in the United States
Read More

Related Posts

Alliance Entertainment CEO Jeffrey Walker buys $2.69 billion in stock

Alliance Entertainment CEO Jeffrey Walker buys $2.69 bi...

President Prabowo Inaugurates Pegadaian Gold Bank Service, BRI Group Optimistic in Strengthening the National Economy

President Prabowo Inaugurates Pegadaian Gold Bank Servi...

Dollar firms as Trump's tariffs loom, yen set for monthly gain

Dollar firms as Trump's tariffs loom, yen set for month...

Home-builder ETFs down in 2025 after brutal February as these worries weigh

Home-builder ETFs down in 2025 after brutal February as...

Autodesk says it’s cutting 9% of its workforce, and shares rise

Autodesk says it’s cutting 9% of its workforce, and sha...

Japan factory output contracts as expected in Jan, retail sales jump

Japan factory output contracts as expected in Jan, reta...